Switzerland: Pharmaceutical products
HS chapter 30 · Chemicals
Pharmaceutical products
Switzerland pharmaceutical products over time
US$, annual.
In more detail
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$43.9 billion | 49.3% |
| 3002 Human blood | US$43.4 billion | 48.8% |
| 3003 Medicaments | US$878.0 million | 1.0% |
| 3006 Pharmaceutical goods | US$713.4 million | 0.8% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$45.8 million | 0.1% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$24.3 million | 0.0% |
| Product | Value | Share |
|---|---|---|
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$42.7 billion | 48.0% |
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$40.1 billion | 45.1% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$2.2 billion | 2.4% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$1.1 billion | 1.3% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$865.2 million | 1.0% |
| 300210 Blood: human and animal, antisera and other blood fractions | US$526.5 million | 0.6% |
| 300640 Pharmaceutical goods: dental cements and other dental fillings, bone reconstruction cements | US$377.7 million | 0.4% |
| 300220 Vaccines: for human medicine | US$178.1 million | 0.2% |
| 300620 Pharmaceutical goods: blood-grouping reagents | US$177.0 million | 0.2% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$153.9 million | 0.2% |
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$47.4 billion | 70.2% |
| 3002 Human blood | US$19.5 billion | 28.8% |
| 3006 Pharmaceutical goods | US$246.6 million | 0.4% |
| 3003 Medicaments | US$200.2 million | 0.3% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$129.5 million | 0.2% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$49.8 million | 0.1% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$42.8 billion | 63.4% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$19.1 billion | 28.2% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$3.2 billion | 4.7% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$1.0 billion | 1.5% |
| 300220 Vaccines: for human medicine | US$260.3 million | 0.4% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$229.1 million | 0.3% |
| 300320 Medicaments: containing antibiotics other than penicillins, streptomycins and their derivatives, for therapeutic or prophylactic uses, (not in measured doses, not packaged for retail sale) | US$121.6 million | 0.2% |
| 300210 Blood: human and animal, antisera and other blood fractions | US$107.9 million | 0.2% |
| 300450 Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | US$94.1 million | 0.1% |
| 300630 Pharmaceutical goods: opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | US$79.1 million | 0.1% |
Shares are of Switzerland's pharmaceutical products in the same direction. See Pharmaceutical products for all countries or all of Switzerland's trade.
More Switzerland products
- 71 Natural, cultured pearls
- 91 Clocks and watches and parts thereof
- 29 Organic chemicals
- 84 Machinery and mechanical appliances, boilers, nuclear reactors
- 90 Optical, photographic, cinematographic, measuring, checking, medical or surgical instruments and apparatus
- 87 Vehicles
- 85 Electrical machinery and equipment and parts thereof
- 27 Mineral fuels, mineral oils and products of their distillation
- 39 Plastics and articles thereof
- 74 Copper and articles thereof
- 94 Furniture
- 62 Apparel and clothing accessories
Switzerland pharmaceutical products: questions and answers
How much pharmaceutical products does Switzerland export?
In 2024, Switzerland exported US$88.9 billion of pharmaceutical products (HS chapter 30), 22.3% of its total exports. That ranks it 5 of 213 exporting countries in the data.
What are Switzerland's biggest pharmaceutical products exports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$43.9 billion), Human blood (3002, US$43.4 billion), Medicaments (3003, US$878.0 million).
How much pharmaceutical products does Switzerland import?
In 2024, Switzerland imported US$67.5 billion of pharmaceutical products (HS chapter 30), 17.8% of its total imports. That ranks it 4 of 226 importing countries in the data.
What are Switzerland's biggest pharmaceutical products imports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$47.4 billion), Human blood (3002, US$19.5 billion), Pharmaceutical goods (3006, US$246.6 million).
